Philadelphia Campus

The objective of the study is to better define and outline the clinical spectrum of SYNGAP1 through detailed developmental, seizure, and quality of life assessments as an extension of routine clinical care.

This study is for people with a genetic mutation in the coagulation (blood clotting) Factor 9 gene that causes severe or moderately severe hemophilia B.

The purpose of this study is to assess the efficacy, safety, and how the body interacts with an investigational drug in pediatric patients with Crohn's disease who have not had success with other medications.

This study enrolls patients with refractory, progressive, or relapsed solid tumors.

This study enrolls patients with cancer diagnoses who are expected to be hospitalized (inpatient) for at least 21 days.

This study aims to explore a new type of magnetic resonance imaging (MRI) called Chemical Exchange Saturation Transfer (CEST) in children aged 6-18 years with brain tumors.

This study focuses on a new type of magnetic resonance imaging (MRI) called Magnetic Resonance Elastography (MRE) for children aged 6-18 years, both with and without brain tumors.

This study aims to explore a special type of magnetic resonance imaging (MRI) called Diffusion Tensor Imaging (DTI) in children aged 0-6 months and 6-17 years.

This study is for children ages 6-18 years, both with and without brain tumors.

This clinical trial is for patients with congenital hyperinsulinism (HI) who are experiencing low blood sugar on their current treatment.